Health Editorial | Updated September 2026
One of the hardest things about prostate cancer is that it can give a man very little warning.
A man can have early prostate cancer and feel completely normal. There may be no pain, no obvious change in urination and no sign that anything is wrong. Then there is the opposite problem: a weak urine stream or waking several times at night can send someone searching the internet for “prostate cancer symptoms”, even though those same symptoms are often caused by an enlarged prostate or another non-cancerous condition.
That gap between what people fear and what the symptoms actually mean is where much of the confusion around prostate cancer begins.
This guide takes a closer look at the disease without treating a symptom checklist as a diagnosis. It covers the early signs, causes and risk factors, PSA testing and screening, prostate cancer stages, surgery and radiation, hormone treatment, metastatic disease and survival rates. It also looks at several questions that frequently send people down very different internet rabbit holes, including whether prostate cancer is hereditary, whether ejaculation has any protective effect and what people mean when they search for “signs you are dying of prostate cancer.”
Understanding symptoms, risk factors and treatment options can make a prostate cancer discussion more useful and less frightening.
The first thing to understand: early prostate cancer may have no symptoms
The phrase early signs of prostate cancer can be misleading because early disease often produces none.
The NHS explains that prostate cancer usually begins in the outer part of the prostate. Because that area is away from the urethra, a tumour may grow for some time before it interferes with urination. NHS: Prostate cancer symptoms.
When symptoms do develop, they can include difficulty starting to urinate, a weak or interrupted flow, needing to urinate frequently or urgently, waking at night to urinate, or feeling that the bladder has not emptied completely. Blood in the urine or semen and erectile difficulties can also occur. Back pain and unexplained weight loss may be associated with more advanced disease.
These are possible symptoms, not a diagnostic fingerprint. A urinary symptom can be important without necessarily being cancer.
Benign prostatic hyperplasia, commonly called BPH, can produce several of the same urinary symptoms. Prostatitis and other prostate or urinary conditions can also affect PSA levels and cause urinary discomfort. National Cancer Institute: PSA Fact Sheet.
So if a man notices a weaker stream, the sensible question is not “Do I have prostate cancer?” It is “Why has this changed, and should I get it checked?”
An illustrative scenario: when a urinary symptom tells only half the story
Consider this example: a 59-year-old man starts getting up three times every night to urinate. He searches for “signs of prostate cancer in men” and becomes convinced that the symptom means cancer.
His doctor may find that he has an enlarged prostate rather than cancer. Another man of exactly the same age could have almost no urinary symptoms and still have prostate cancer discovered after an assessment prompted by his risk profile or PSA result.
This is why symptom lists have limits. The presence of symptoms does not prove cancer, and their absence does not rule it out.
What causes prostate cancer?
People often search what causes prostate cancer as though there is one identifiable trigger. There isn’t.
Prostate cancer develops when cells acquire genetic changes that allow them to grow and divide abnormally. Some genetic changes develop during a person’s lifetime, while others can be inherited. Researchers have identified several inherited gene changes associated with prostate cancer, including BRCA1, BRCA2 and genes involved in Lynch syndrome. National Cancer Institute: Prostate Cancer Genetics.
Age is one of the clearest risk factors. Risk rises substantially as men get older. Family history matters too, particularly when a father, brother or son has had prostate cancer. The NHS also identifies Black African and Black Caribbean men as having a higher risk and notes that a family history of certain other cancers, including breast, ovarian and pancreatic cancer, can be relevant because some inherited genes overlap. NHS: Prostate cancer causes and risk factors.
One useful correction to common internet advice is that an enlarged prostate does not itself mean a man is developing prostate cancer. BPH and prostatitis are not considered risk factors for prostate cancer.
Is prostate cancer hereditary?
Is prostate cancer hereditary? Sometimes. Most cases are not simply inherited in a straightforward parent-to-child pattern, but inherited genetic changes can raise risk.
The family pattern becomes particularly important when several close relatives have prostate cancer or when relatives developed prostate, breast, ovarian or pancreatic cancers at relatively young ages. In such situations, a doctor may consider whether genetic counselling or testing is appropriate.
This is one area where knowing your family history can be more useful than memorising dozens of symptoms. A man who knows that his father and brother both had prostate cancer has information that can change a conversation about screening even if he feels perfectly healthy.
Prostate cancer screening: the PSA question is more complicated than it looks
Prostate cancer screening usually involves discussion of the PSA blood test and, depending on the circumstances, a digital rectal examination or further testing.
PSA stands for prostate-specific antigen. It is produced by prostate cells, including normal cells. A raised PSA can occur with prostate cancer, but also with benign prostate enlargement, prostatitis and other non-cancerous conditions. National Cancer Institute: PSA testing.
PSA is not a cancer verdict. A raised PSA can be an important reason for further investigation, but the number alone cannot diagnose prostate cancer.
This is why a high PSA should not be translated into “I have cancer.” It is a signal that may require further investigation.
The NCI notes that there is no standard routine screening test that is appropriate for everyone and that PSA screening has potential benefits as well as harms. These include false-positive results, unnecessary biopsies and the detection of cancers that might never have caused symptoms or become life-threatening. National Cancer Institute: Prostate Cancer Screening.
In the UK, the NHS does not offer routine PSA testing to every man. Men can discuss testing with a GP, particularly if they have symptoms or a higher-than-average risk. NHS: PSA test.
There is a practical lesson here: screening is a decision, not simply a blood test.
A man should ideally understand why the test is being considered, what a raised result might lead to, and what the possible consequences of further testing and treatment could be.
Prostate health is influenced by risk awareness, screening discussions and overall health habits.
How do you know if you have prostate cancer?
There is no reliable way to diagnose prostate cancer from symptoms alone.
A doctor may start with a discussion of symptoms and medical and family history, followed by a PSA test. If the findings raise concern, further investigation can include imaging such as an MRI and a prostate biopsy. A biopsy examines prostate tissue under a microscope and can establish whether cancer is present and how abnormal the cancer cells appear.
This matters because the eventual treatment decision depends on much more than whether a biopsy says “cancer.” Doctors also need to understand the cancer’s grade, extent and risk of progression.
Prostate cancer stages: why stage changes the conversation
Prostate cancer stages describe how far the disease has spread.
In broad terms, stage 1 and stage 2 cancers are confined to the prostate, although their size, grade and risk can differ considerably. Stage 3 indicates cancer that has grown beyond the prostate or into nearby structures. Stage 4 refers to more advanced disease, including spread to nearby lymph nodes or distant parts of the body.
Stage is only one part of the picture. PSA, biopsy findings, Gleason score or Grade Group and imaging results also help doctors determine risk and treatment options.
This explains another common search misconception: stage 1 prostate cancer symptoms may be absent. A person cannot determine their stage by counting symptoms. Staging happens after medical investigation.
Prostate cancer treatment is not one-size-fits-all
The treatment of prostate cancer depends on the behaviour and extent of the disease, as well as the person’s age, general health and preferences.
For some men with low-risk cancer, active surveillance may be recommended. This means the cancer is monitored with tests and scans rather than immediately treated. The NHS explains that some prostate cancers grow so slowly that treatment may never become necessary, while treatment itself can cause significant long-term side effects. NHS: Prostate cancer treatment.
For cancer that remains localised, treatment options can include surgery or radiotherapy. More advanced disease may require hormone therapy, chemotherapy and other systemic treatments.
This is one of the areas where online discussions can become misleading. “Cancer treatment” does not automatically mean chemotherapy, and “having cancer” does not automatically mean immediate surgery.
Prostate cancer surgery: what happens after the operation?
Prostate cancer surgery generally means radical prostatectomy, in which the prostate gland is removed.
For appropriate men with localised disease, surgery can be a potentially curative treatment. But it comes with trade-offs. The NHS lists urinary leakage, erectile dysfunction and changes in orgasm or ejaculation among possible consequences. A radical prostatectomy also removes the ability to father a child through sex because semen is no longer ejaculated in the normal way. NHS: Prostate cancer treatment.
That is why a serious treatment discussion should include life after treatment, not just the cancer itself.
A man considering surgery may reasonably want to ask about continence recovery, sexual function, fertility, nerve-sparing approaches where appropriate and what happens if the PSA later rises.
Radiation treatment and its side effects
Radiotherapy uses high-energy radiation to destroy cancer cells. It can be used for localised or locally advanced prostate cancer and can also be used to control symptoms or slow disease that has spread.
Side effects of radiation for prostate cancer can include urinary frequency or irritation, bowel changes and sexual problems. Some effects settle after treatment, while others can persist.
The important comparison is therefore not simply surgery versus radiation. Each treatment has a different pattern of potential benefits, risks and long-term effects. The right comparison depends on the individual’s cancer and priorities.
What is the hormone shot for prostate cancer?
The phrase hormone shot for prostate cancer usually refers to hormone therapy used to reduce the effect of testosterone on prostate cancer cells.
Testosterone can help prostate cancer grow. Hormone injections and tablets can reduce testosterone production or block its effects. Hormone therapy may be used alongside radiotherapy for some localised or locally advanced cancers and is also central to the management of many advanced cancers. NHS: Prostate cancer treatment.
Possible effects include hot flushes, reduced sexual desire, erectile problems and other changes associated with lower androgen levels. For advanced disease, hormone treatment can control cancer for a significant period, although hormone therapy alone is not generally considered a cure.
Metastatic prostate cancer: what stage 4 really means
Metastatic prostate cancer means the cancer has spread from the prostate to distant parts of the body. Bone is a common site of spread, although lymph nodes and organs such as the liver or lungs can also be involved.
When prostate cancer spreads to bone, it remains prostate cancer. It does not become a new primary bone cancer.
Advanced disease can cause persistent bone or back pain, weight loss, fatigue or urinary problems. New weakness or numbness in the legs, particularly with bladder or bowel problems, can be an emergency because cancer affecting the spine can compress nerves.
People searching for “signs you are dying of prostate cancer” are often trying to understand a frightening situation involving someone they love. There is no universal timetable or symptom checklist that can tell a family exactly when death is approaching. Advanced cancer can look very different from one person to another, and the treating oncology or palliative-care team is better placed to explain what changes mean in an individual case.
Seek urgent medical attention for new severe neurological symptoms. New leg weakness or numbness, or new bladder or bowel control problems in someone with known metastatic prostate cancer can require urgent assessment.
Prostate cancer survival rate: the numbers need context
The phrase prostate cancer survival rate sounds precise, but survival statistics are population measures, not personal predictions.
In the United States, the American Cancer Society reports 5-year relative survival above 99% for men whose prostate cancer is localised or regional at diagnosis, compared with 38% for distant disease. These figures are based on men diagnosed between 2015 and 2021. American Cancer Society: Prostate Cancer Survival Rates.
Population survival data show a major difference between localised disease and cancer that has spread to distant parts of the body. These numbers help describe outcomes across groups; they do not predict an individual patient’s future.
The latest NHS England cancer survival publication, released in April 2026, covers adults diagnosed with cancer in England between 2018 and 2022 and followed through the end of 2023. It reports an age-standardised 5-year net survival estimate of 89.5% for prostate cancer overall. For prostate cancer by stage, the reported 5-year estimate is 102.3% for stage 1 and 54.8% for stage 4. NHS England: Cancer Survival in England.
The stage 1 figure above 100% may look strange, but it does not mean that more than 100% of men survive. NHS England explains that these are net-survival estimates and that values above 100% can occur because the calculation compares cancer survival with expected survival in the general population.
The practical point is much simpler: stage at diagnosis has a major relationship with outcome, but age, tumour grade, PSA, overall health and response to treatment also matter. The American Cancer Society specifically warns that survival statistics cannot tell an individual person how long they will live.
Can prostate cancer be cured?
Is prostate cancer curable? In many men with cancer that remains confined to the prostate, treatment can potentially eliminate the disease. Surgery and radiotherapy are both used with curative intent in appropriate cases.
Once prostate cancer has spread to distant parts of the body, the situation is different. Metastatic prostate cancer is usually treated as a long-term disease. Modern hormone therapy and other systemic treatments can control it, sometimes for years, but the expectation is generally disease control rather than removing every cancer cell from the body.
That distinction matters because “stage 4” is not a single experience. Metastatic prostate cancer can respond very differently from one patient to another.
How to avoid prostate cancer: what can actually be done?
There is no guaranteed way to avoid prostate cancer.
Some of the strongest risk factors, including age and inherited genetic susceptibility, cannot be changed. Maintaining a healthy weight, staying physically active and eating a balanced diet are sensible for overall health, but no lifestyle plan can promise that a man will never develop prostate cancer.
Another frequently searched question is “does ejaculation help prevent prostate cancer?” Some observational research has reported an association between more frequent ejaculation and a lower risk of prostate cancer, but this does not establish that ejaculation prevents cancer. It should not be presented as a proven prevention method.
Interestingly, the NHS advises avoiding ejaculation for 48 hours before a PSA test because ejaculation can temporarily raise PSA and make the result less accurate. NHS: PSA test.
Healthy habits support overall wellbeing, but lifestyle choices cannot guarantee prevention of prostate cancer.
Can women get prostate cancer?
Can women get prostate cancer? Conventional prostate cancer arises in prostate tissue, so people who do not have a prostate cannot develop prostate cancer in the usual medical sense.
There is a small anatomical complication: some women have paraurethral glands, commonly known as Skene’s glands, which are sometimes referred to as the female prostate. Rare cancers can arise from these glands, but they are not the same disease as the prostate cancer normally discussed in men.
Prostate Cancer Awareness Month: why awareness still matters
Prostate Cancer Awareness Month takes place in September in several awareness campaigns. The useful purpose of a month like this is not to encourage everyone to panic over every urinary symptom. It is to remind people that risk can exist before symptoms appear and that family history deserves attention.
A man over 50, a Black man, or someone with a strong family history of prostate or certain related cancers may have a different risk profile from an otherwise similar person. The NHS specifically advises people concerned about their risk to speak with a GP even when they have no symptoms.
Prostate cancer ICD-10: what does C61 mean?
If you see prostate cancer ICD-10 on a medical record, insurance document or cancer registry report, the ICD-10 code commonly associated with malignant neoplasm of the prostate is C61.
The code identifies the disease category. It does not, by itself, tell you whether the cancer is stage 1 or stage 4, how aggressive it is, or what treatment should be used.
C61 identifies malignant neoplasm of the prostate. It is a classification code, not a measure of severity, stage or prognosis.
A clear conversation with a healthcare professional can help put symptoms, screening results and risk factors into context.
The questions that matter after diagnosis
Once prostate cancer is confirmed, the most useful questions are often more specific than “How serious is it?”
- What is my PSA level?
- What is my Gleason score or Grade Group?
- Is the cancer confined to the prostate?
- What stage is it?
- What did the MRI show?
- Is active surveillance reasonable?
- What would surgery mean for urinary and sexual function?
- What side effects are most likely with radiotherapy?
- Would hormone therapy be needed?
- Has the cancer spread anywhere else?
- Should genetic testing be considered because of my family history?
Those questions turn a frightening diagnosis into something that can actually be understood and discussed.
The bottom line
Prostate cancer is not one uniform disease. Some cancers grow slowly enough to monitor. Others require treatment soon after diagnosis. Some remain confined to the prostate, while metastatic disease may require long-term systemic treatment.
The most important misconception to leave behind is that symptoms alone can tell you whether you have prostate cancer. They cannot. Early disease may have no symptoms, while common urinary symptoms may have entirely non-cancerous causes. PSA can provide useful information, but it is not a cancer verdict.
For someone wondering “how do you know if you have prostate cancer?”, the answer is ultimately a medical assessment rather than an online checklist. Persistent urinary changes, blood in the urine or semen, unexplained weight loss, ongoing bone or back pain, or other concerning changes deserve appropriate medical attention. And for men with higher-risk family or genetic backgrounds, the screening conversation may be worth having before symptoms appear.
That is perhaps the most useful way to think about prostate cancer awareness: the goal is not to turn every symptom into cancer. It is to make sure that a potentially important change is not dismissed simply because it seems ordinary.
Frequently Asked Questions About Prostate Cancer
What are the early signs of prostate cancer?
Early prostate cancer often causes no symptoms. When symptoms occur, they may include difficulty starting urination, a weak or interrupted urine stream, frequent urination, waking at night to urinate, blood in urine or semen, and erectile difficulties. These symptoms can also have non-cancerous causes, so they cannot diagnose prostate cancer by themselves.
How do you know if you have prostate cancer?
Symptoms alone cannot confirm prostate cancer. A doctor may consider symptoms, family history and risk factors, then use PSA testing and, when appropriate, MRI and prostate biopsy. A biopsy can confirm whether cancer cells are present.
What causes prostate cancer?
There is no single cause. Prostate cancer develops through genetic changes that allow prostate cells to grow abnormally. Age, family history, inherited genetic changes and certain population-level risk factors can increase the likelihood of developing the disease.
Is prostate cancer hereditary?
Some prostate cancers are linked to inherited genetic changes, but most cases are not simply inherited. A strong family history of prostate, breast, ovarian or pancreatic cancer can be relevant and may justify discussion of genetic counselling or testing.
Is prostate cancer curable?
Some localised prostate cancers can potentially be cured with treatment such as surgery or radiotherapy. Metastatic prostate cancer is generally managed as a long-term disease, with treatment aimed at controlling the cancer, reducing symptoms and extending survival.
What does stage 4 prostate cancer mean?
Stage 4 prostate cancer is advanced disease that has spread beyond the prostate. It may involve nearby lymph nodes or distant parts of the body. Bone is a common site of metastatic prostate cancer, although other organs can also be affected.
What is a hormone shot for prostate cancer?
A hormone injection is commonly used as part of androgen-deprivation therapy. It reduces testosterone production or blocks its effects, limiting hormonal signals that can help prostate cancer grow. It is used in several settings, including some higher-risk localised cancers and many advanced cancers.
Does ejaculation help prevent prostate cancer?
Some observational studies have reported an association between more frequent ejaculation and a lower risk of prostate cancer, but this does not prove that ejaculation prevents cancer. It should not be treated as an established prevention strategy.
What are the side effects of radiation for prostate cancer?
Radiotherapy can cause urinary irritation or increased frequency, bowel changes, fatigue and sexual problems. Some side effects improve after treatment, while others may persist. The likelihood depends on the treatment method and individual circumstances.
Can women get prostate cancer?
Conventional prostate cancer develops in prostate tissue. People who do not have a prostate cannot develop conventional prostate cancer. Rare cancers can arise from paraurethral glands in women, sometimes called the female prostate, but these are different diseases.
What is the ICD-10 code for prostate cancer?
The ICD-10 code commonly used for malignant neoplasm of the prostate is C61. The code identifies the disease category and does not by itself describe the cancer’s stage, grade or prognosis.
What is the prostate cancer survival rate?
Survival varies substantially by stage and other clinical factors. Recent US data show 5-year relative survival above 99% for localised or regional disease and 38% for distant disease. NHS England’s latest published data also show substantial differences by stage. Population statistics cannot predict an individual’s outcome.
Medical Sources & Further Reading
This article uses information from established medical and public-health sources. Readers should consult the original sources and a qualified healthcare professional for individual medical decisions.
- NHS — Prostate cancer symptoms
- NHS — Causes and risk factors of prostate cancer
- NHS — Prostate cancer treatment
- NHS — PSA test
- National Cancer Institute — PSA Fact Sheet
- National Cancer Institute — Prostate Cancer Screening
- National Cancer Institute — Prostate Cancer Genetics
- American Cancer Society — Prostate Cancer Survival Rates
- NHS England — Cancer Survival in England
Medical disclaimer: This article is for general health information and is not a diagnosis or substitute for individual medical advice. Prostate cancer testing and treatment decisions should be discussed with a qualified healthcare professional. Anyone with persistent urinary changes, blood in the urine or semen, unexplained weight loss, ongoing bone or back pain, or other concerning symptoms should seek appropriate medical assessment. New leg weakness or numbness, particularly with bladder or bowel control problems in someone with known metastatic cancer, requires urgent medical attention.
